ATAI Life Sciences N.V. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ATAI Life Sciences N.V. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2020 to Q3 2024.
  • ATAI Life Sciences N.V. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$26.3M, a 159% decline year-over-year.
  • ATAI Life Sciences N.V. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$129M, a 92.1% decline year-over-year.
  • ATAI Life Sciences N.V. annual Net Income (Loss) Attributable to Parent for 2023 was -$40.2M, a 73.6% increase from 2022.
  • ATAI Life Sciences N.V. annual Net Income (Loss) Attributable to Parent for 2022 was -$152M, a 9.19% increase from 2021.
  • ATAI Life Sciences N.V. annual Net Income (Loss) Attributable to Parent for 2021 was -$168M, a 1.2% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$129M -$26.3M -$70.5M -159% Jul 1, 2024 Sep 30, 2024 10-Q/A 2024-11-14
Q2 2024 -$58.1M -$57.3M -$24.3M -73.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$33.8M -$26.7M +$6.42M +19.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$40.2M -$18.3M +$26.7M +59.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$66.9M $44.2M +$78.1M Jul 1, 2023 Sep 30, 2023 10-Q/A 2024-11-14
Q2 2023 -$145M -$33M +$3.58M +9.77% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$149M -$33.1M +$3.73M +10.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$152M -$45M +$43.9M +49.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$196M -$33.9M -$2.73M -8.76% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$194M -$36.6M +$11.8M +24.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$205M -$36.9M -$37.6M -5459% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$168M -$88.9M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-24
Q3 2021 -$31.2M +$52M +62.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$48.5M -$32.1M -196% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $688K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 -$83.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$16.4M Apr 1, 2020 Jun 30, 2020 10-Q/A 2021-08-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.